Periprosthetic osteolysis and its association with RANKL expression

Physiological Research

Volumn 56, Issue 4, 2007, Pages 455-462

  Veigl, D ^a,c   Niederlova J ^b   Krystufkova O ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^c NONE   (Czech Republic)

Author keywords

Leptin; Periprosthetic osteolysis; RANK; RANKL

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; TNFSF11 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHEMISTRY; FEMUR; HIP; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; INSTRUMENTATION; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PATHOLOGY; PROSTHESIS FAILURE; REOPERATION;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; FEMUR; HIP JOINT; HIP PROSTHESIS; HUMANS; MIDDLE AGED; OSTEOLYSIS; PROSTHESIS FAILURE; RANK LIGAND; REOPERATION;

EID: 35649019710     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BAUMANN B, RADER CP, SEUFERT J, NOTH U, ROLF O, EULERT J, JAKOB F: Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthop Scand 75: 295-302, 2004.
2. CHUN L, YOON J, SONG Y, HUIE P, REGULA D, GOODMAN S: The characterization of macrophages and osteoclasts in tissues harvested from revised total hip prostheses. J Biomed Mater Res 48: 899-903, 1999.
3. CLOHISY JC, FRAZIER E, HIRAYAMA T, ABU-AMER Y: RANKL is essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res 21: 202-212, 2003.
4. EPSTEIN NJ, WARME BA, SPANOGLE J, MA T, BRAGG B, SMITH RL, GOODMAN SB: Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 23: 501-510, 2005.
5. FUJIKAWA Y, QUINN J, SABOKBAR A, MCGEE JÓD, ATHANASOU NA: The human mononuclear osteoclast precursor circulates in the monocyte fraction. Endocrinology 139: 4058-4060, 1996.
6. HALUZÍK M, FIEDLER J, NEDVÍDKOVÁ J, ČEŠKA R: Serum leptin concentrations in patients with combined hyperlipidemia: relationship to serum lipids and lipoproteins. Physiol Res 48: 363-368, 1999.
7. HALUZÍK M, MATOULEK M, SVAČINA S, HILGERTOVÁ J, HAAS T: The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocr Res 27: 251-260, 2001.
8. HAYNES DR, ROGERS SD, HAY S, PEARCY MJ, HOWIE DW: The differences in toxicity and release of bone resorbing mediators induced by titanium and cobal-chromium-alloy wear particles. J Bone Joint Surg Am 75: 825-833, 1993.
9. HAYNES DR, CROTTI TN, POTTER AE, LORIC M, ATKINS GJ, HOWIE DW, FINDLAY DM: The osteoclastogenesis molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 83: 902-911, 2001.
10. HOFBAUER LC, KHOSLA S, DUNSTAN CR, LACEY DL, BOYLE WJ, RIGGS BL: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12, 2000.
11. HORIKI M, NAKASE T, MYOUI A, SUGANO N, NISHII T, TOMITA T, MIYAJI T, YOSHIKAWA H: Localisation of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 22: 346-351, 2004.
12. ITONAGA I, FUJIKAWA Y, SABOKBAR A, ATHANASOU NA: The effect of osteoprotegerin and osteoprotegerin ligand on human arthroplasty macrophage-osteoclast differentiation. Ann Rheum Dis 59: 26-31, 2000.
13. JAHODA D, VAVŘÍK P, LANDOR I, POKORNÝ D: The approaches to infection of knee prostheses joint in patients with rheumatoid arthritis. (in Czech) Čes Revmatol 8: 83-90, 2000.
14. JAHODA D, SOSNA A, LANDOR I, VAVŘÍK P, POKORNÝ D: Canalized spacer in the treatment of deep infection of the total hip arthroplasty using a two-stage reimplantation. Operative Orthopaedie Traumatologie 15: 57-69, 2003a.
15. JAHODA D, SOSNA A, LANDOR I, VAVŘÍK P, POKORNÝ D, HUDEC T: Two-stage reimplantation using spacers-the method of choice in treatment of hip joint prosthesis-related infections. Comparison with methods used from 1979 to 1998. (in Czech) Acta Chir Orthop Traumatol Cech 70: 17-24, 2003b.
16. JAHODA D, SOSNA A, LANDOR I, VAVŘÍK P, POKORNÝ D: A cannulated articulating spacer - a functional implant for treatment of infected hip joint prostheses. (in Czech) Acta Chir Orthop Traumatol Cech 71: 73-79, 2004.
17. KŘÍŽOVÁ J, SULKOVÁ S, BEDNÁŘOVÁ V, PAŘÍZKOVÁ J, KOTRLÍKOVÁ E, HALUZÍK M: Soluble leptin receptor levels in patients with chronic renal failure. Physiol Res 52: 347-351, 2003.
18. LACEY DL, TIMMS E, TAN HL, KELLEY MJ, DUNSTAN CR, BURGESS T, ELLIOTT R, COLOMBERO A, ELLIOTT G, SCULLY S, HSU H, SULLIVAN J, HAWKINS N, DAVY E, CAPPARELLI C, ELI A, QIAN YX, KAUFMAN S, SAROSI I, SHALHOUB V, SENALDI G, GUO J, DELANEY J, BOYLE WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176, 1998.
19. LANDOR I, VAVŘÍK P, HAVELKA S, JAHODA D: Factors affecting the development of para-articular ossification in total hip replacement. (in Czech) Acta Chir Orthop Traumatol Cech 60: 76-80, 1993.
20. LANDOR I, SOSNA A, FRIČ V, JAHODA D: First pilot results with non-cemented total substitution of the hip joint. (in Czech) Acta Chir Orthop Traumatol Cech 61: 132-137, 1994.
21. LANDOR I, SOSNA A, VAVŘÍK P, POVÝŠIL C, JAHODA D: Clinical study of the effect of hydroxyapatite on the osteointegration by total hip replacement. Chir Organi Mov 82: 381-392, 1997.
22. LANDOR I, VAVŘÍK P, JAHODA D: General principles of infection treatment in joint replacements. (in Czech) Acta Chir Orthop Traumatol Cech 72: 183-190, 2005.
23. MANDELIN J, LI TF, LILJESTROM M, KROON ME, HANEMAAIJER R, SANTAVIRTA S, KONTTINEN YT: Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Br 85: 1196-1201, 2003.
24. MASUI T, SAKANO S, HASEGAWA Y, WARASHINA H, ISHIGURO N: Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles. Biomaterials 26: 1695-1702, 2005.
25. MARUNA P, GURLICH R, FRAŠKO R, HALUZÍK M: Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI. Physiol Res 50: 589-594, 2001.
26. PANDEY R, QUINN J, JOYNER C, TRIFFITT JT, ATHANASOU NA: Arthroplasty implant biomaterial particle-associated macrophages differentiate into osteoclastic bone-resorbing cells. Ann Rheum Dis 55: 388-395, 1996.
27. SABOKBAR AS, FUJIKAWA Y, NEALE S, MURRAY D, ATHANASOU NA: Human arthroplasty derived macrophages differentiate into osteoclastic bone-resorbing cells. Ann Rheum Dis 56: 414-420, 1997.
28. SCHMALZRIED TP, JASTY M, HARRIS WH: Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am 74: 849-863, 1992.
29. SOSNA A, BEZNOSKA J, JAHODA D, LANDOR I: Non-cemented ceramic acetabular component. Acta Chir Orthop Traumatol Cech 63: 189-195, l996 (in Czech).
30. ŠLOUF M, ŠLOUFOVÁ I, HORÁK Z, ŠTĚPÁNEK P, ENTLICHER G, KREJČÍK M, RADONSKÝ T, POKORNÝ D, SOSNA A: New fast method for determination of number of UHMWPE wear particles. J Mater Sci Mater Med 15: 1-12, 2004.
31. TAKEI I, TAKAGI M, IDA H, OGINO T, SANTAVIRTA S, KONTINNEN YT: High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints. J Rheumatol 27: 894-899, 2000.
32. VAVŘK P LANDOR I, JAHODA D: The results of treating the alloplastic knee joint. Acta Chir Orthop Traumatol Cech 67: 121-127, 2000 (in Czech).
33. VON KNOCH M, JEWISON DE, SIBONGA JD, SPRECHER C, MORREY BF, LOER F, BERRY DJ, SCULLY SP: The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res 22: 237-243, 2004.
34. YASUDA H, SHIMA N, NAKAGAWA N, YAMAGUCHI K, KINOSAKI M, MOCHIZUKI S, TOMOYASU A, YANO K, GOTO M, MURAKAMI A, TSUDA E, MORINAGA T, HIGASHIO K, UDAGAWA N, TAKAHASHI N, SUDA T: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-3602, 1998.